Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Stemline Therapeutics Inc (NASDAQ:STML)

9.61
Delayed Data
As of Aug 28
 +0.48 / +5.26%
Today’s Change
8.31
Today|||52-Week Range
18.94
-43.67%
Year-to-Date
No recent news for Stemline Therapeutics Inc.

Today’s Trading

Previous close9.13
Today’s open9.10
Day’s range8.94 - 9.71
Volume58,182
Average volume (3 months)94,276
Market cap$172.7M
Dividend yield--
Data as of 3:59pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)+5.11%
Earnings growth (this year)+0.72%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.30

Competitors

 Today’s
change
Today’s
% change
VTAEVitae Pharmaceutical...+0.15+1.91%
MSLIMerus Labs Internati...-0.05-2.94%
ADHDAlcobra Ltd+0.18+2.32%
RPRXRepros Therapeutics ...+0.17+2.36%
Data as of 3:59pm ET, 08/28/2015

Financials

Next reporting dateNovember 11, 2015
EPS forecast (this quarter)-$0.59
Annual revenue (last year)$0.00
Annual profit (last year)-$28.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Ivan Bergstein
Chief Operating Officer &
Secretary
Kenneth Hoberman
Corporate headquarters
New York, New York

Forecasts

Partner Offers